Ascentage Pharma Group International Balance Sheet (2022-2025) | AAPG

Balance Sheet Dec2022 Dec2023 Dec2024 Jun2025
Assets
Current Assets
Cash & Equivalents 189.20M144.17M122.35M
Cash & Current Investments 189.20M144.17M122.35M
Receivables - Net 20.26M11.39M10.83M
Receivables - Other 0.92M0.84M
Receivables 21.18M12.23M10.83M
Work In Process 0.71M0.37M
Finished Goods 1.54M0.53M
Inventory 2.25M0.90M1.19M
Prepaid Assets 12.26M16.88M
Current Assets 186.69M201.96M263.89M
Non-Current Assets
Property, Plant & Equipment (Net) 125.81M116.37M113.53M
Long-Term Investments 2.36M4.48M4.52M
Goodwill 3.43M3.38M3.41M
Intangibles 11.85M11.87M10.41M9.82M
Goodwill & Intangibles 11.85M15.30M13.79M13.23M
Long-Term Deferred Tax 8.38M8.31M6.98M4.62M
Other Non-Current Assets 2.33M3.41M8.12M13.69M
Non-Current Assets 160.58M156.68M157.25M
Liabilities
Current Liabilities
Accounts Payables 10.06M12.60M
Accumulated Expenses 0.57M2.03M
Other Accumulated Expenses 35.93M34.47M
Current Leases 1.36M1.29M0.21M
Current Deferred Revenue 5.33M5.13M5.18M
Total Current Liabilities 129.74M159.82M249.80M
Non-Current Liabilities
Non-Current Deffered Revenue 34.89M34.04M
Preferred Stock Liabilities 113.53M
Operating Leases 2.42M3.15M4.14M
Non-Current Deferred Tax Liability 2.46M2.22M1.66M
Other Non-Current Liabilities 2.54M0.86M
Total Non-Current Liabilities 207.72M161.25M
Total Liabilities 337.46M321.08M
Shareholder's Equity
Common Equity 57.46M9.81M37.56M
Shareholder's Equity 57.46M9.81M37.56M
Treasury Shares 2.97M0.00M
Retained Earnings -745.15M-790.56M